Xuan Yao Selected Research

Xuan Yao Research Topics

Disease

10	Neoplasms (Cancer) 04/2022 - 01/2012
4	COVID-19 01/2022 - 06/2020
3	Body Weight (Weight, Body) 11/2022 - 12/2018
3	Infections 01/2022 - 12/2018
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2021 - 01/2018
2	Disease Progression 01/2022 - 07/2014
2	Liver Failure 12/2018 - 06/2017
2	Hypothyroidism 04/2015 - 01/2014
1	Reperfusion Injury 02/2022
1	Fibrosis (Cirrhosis) 02/2022
1	Glioma (Gliomas) 01/2022
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2022
1	Orbital Diseases 01/2022
1	Optic Nerve Diseases (Optic Neuropathy) 01/2022
1	Graves Ophthalmopathy 01/2022
1	Retinal Perforations 01/2022
1	Coinfection 01/2022
1	Retinal Diseases 01/2022
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022
1	Glaucoma 01/2022
1	Hypertensive Retinopathy 01/2022
1	Myopia 08/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2020
1	Rheumatoid Arthritis 12/2020
1	Malignant Mesothelioma 11/2020
1	Synovial Sarcoma (Synovioma) 06/2018
1	Nasopharyngeal Carcinoma 06/2018
1	Melanoma (Melanoma, Malignant) 06/2018
1	Pathologic Constriction (Stenosis) 02/2018
1	Graves Disease (Basedow Disease) 07/2017
1	Atrial Fibrillation 07/2017
1	Infarction (Infarctions) 10/2015
1	Brain Edema (Cerebral Edema) 10/2015
1	Stroke (Strokes) 10/2015
1	Prostatic Neoplasms (Prostate Cancer) 07/2015
1	Hyperglycemia 06/2015
1	Hyperthyroidism 04/2015
1	Pulmonary Hypertension 04/2015
1	Atherosclerosis 04/2015
1	Dyslipidemias (Dyslipidemia) 04/2015

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 02/2022 - 07/2015
3	Peptides (Polypeptides)IBA 11/2020 - 11/2006
3	Biomarkers (Surrogate Marker)IBA 11/2020 - 07/2014
2	LectinsIBA 04/2022 - 01/2019
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 11/2020 - 06/2015
2	AntigensIBA 01/2020 - 06/2018
2	LigandsIBA 01/2019 - 11/2006
2	HLA Antigens (Human Leukocyte Antigens)IBA 06/2018 - 01/2018
2	MicroRNAs (MicroRNA)IBA 07/2017 - 07/2014
2	Triglycerides (Triacylglycerol)IBA 12/2014 - 10/2011
1	Histamine (Histamine Dihydrochloride)FDA Link 11/2022
1	Interleukin-6 (Interleukin 6)IBA 11/2022
1	CytokinesIBA 11/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2022
1	CadmiumIBA 11/2022
1	Blood Glucose (Blood Sugar)IBA 09/2022
1	Amino Acids FDA Link 09/2022
1	Starch (Cornstarch)IBA 09/2022
1	Insulin (Novolin)FDA Link 09/2022
1	Circular RNAIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	16S Ribosomal RNAIBA 01/2022
1	Troleandomycin (TAO)FDA Link 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	HLA-A Antigens (HLA-A)IBA 09/2021
1	Mydriatics (Cycloplegics)IBA 08/2021
1	Biological ProductsIBA 01/2021
1	SmokeIBA 01/2021
1	biochanin AIBA 01/2021
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 12/2020
1	InterferonsIBA 11/2020
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 06/2020
1	VaccinesIBA 06/2020
1	Immunodominant EpitopesIBA 06/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	MucinsIBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2019
1	NK Cell Lectin-Like Receptor Subfamily CIBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	Colistin (Coly-Mycin)FDA Link 12/2018
1	fumarylacetoacetase (fumarylacetoacetate hydrolase)IBA 12/2018
1	Rifampin (Rifampicin)FDA LinkGeneric 12/2018
1	Azithromycin (Zithromax)FDA LinkGeneric 12/2018
1	Therapeutic UsesIBA 12/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2018
1	Aquaporin 4IBA 10/2015
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2015
1	ProstaglandinsIBA 04/2015
1	Thyroid HormonesIBA 04/2015
1	ThromboxanesIBA 04/2015
1	Dinoprostone (PGE2)FDA Link 04/2015

Therapy/Procedure

3	Therapeutics 06/2020 - 06/2017
3	Immunotherapy 01/2020 - 06/2018
1	Organ Transplantation 02/2022